4-butyrolactone has been researched along with Colitis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Sun, KY; Xiong, W; Zhang, X; Zhou, YH; Zhu, Y; Zou, X | 1 |
| Fang, J; Fang, S; Huang, Y; Li, M; Luo, Y; Mei, Y; Pan, H; Wan, T; Wang, Q; Wang, Z; Xue, J; Zhang, Y | 1 |
| Aziz, M; Kameoka, S; Matsuo, S; Wang, P; Yang, WL | 1 |
3 other study(ies) available for 4-butyrolactone and Colitis
| Article | Year |
|---|---|
Metformin alleviates inflammation through suppressing FASN-dependent palmitoylation of Akt.
Topics: 4-Butyrolactone; Animals; Cell Membrane; Colitis; Dextran Sulfate; Down-Regulation; Enzyme Activation; Fatty Acid Synthases; Inflammation; Intestinal Mucosa; Lipopolysaccharides; Lipoylation; Macrophages; Male; Metformin; Mice; Mice, Inbred C57BL; Palmitates; Phosphorylation; Proto-Oncogene Proteins c-akt; RAW 264.7 Cells; Signal Transduction; TOR Serine-Threonine Kinases; Transcription Factor RelA | 2021 |
Systems pharmacology approach uncovers Ligustilide attenuates experimental colitis in mice by inhibiting PPARĪ³-mediated inflammation pathways.
Topics: 4-Butyrolactone; Animals; Biological Products; Colitis; Colon; Cytokines; Dextran Sulfate; Female; Inflammation; Inflammation Mediators; Inflammatory Bowel Diseases; Mice, Inbred C57BL; Models, Biological; Network Pharmacology; NF-kappa B; PPAR gamma; Signal Transduction; Transcription Factor AP-1 | 2021 |
Fatty acid synthase inhibitor C75 ameliorates experimental colitis.
Topics: 4-Butyrolactone; Animals; Chemokines; Colitis; Colon; Cyclooxygenase 2; Cytokines; Dextran Sulfate; Disease Models, Animal; Fatty Acid Synthases; Gene Expression Regulation; Humans; Male; Mice; Mice, Inbred C57BL; Nitric Oxide Synthase Type II | 2014 |